Skip to content

Clinical trials

Phase 1 Squamous Cell Carcinoma of Head and Neck trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20132
20161
20172
20182
20193
20205
20212
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting6
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
AstraZeneca3
Novartis Pharmaceuticals3
Astellas Pharma Global Development, Inc.2
BeiGene1
Boehringer Ingelheim1
Calico Life Sciences LLC1
EMD Serono Research & Development Institute, Inc.1
Eisai Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck26
Carcinoma, Non-Small-Cell Lung12
Neoplasms11
Melanoma8
Colorectal Neoplasms7
Ovarian Neoplasms7
Stomach Neoplasms7
Carcinoma, Renal Cell6
Esophageal Neoplasms6
Esophageal Squamous Cell Carcinoma6

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.